Texas A&M researchers found that in an aggressive kidney cancer, RNA builds “droplet hubs” that activate tumor genes. By creating a molecular switch to dissolve these hubs, they stopped cancer growth ...
Rather than working on the surface of cells like some cancer medicines, small molecules are able to slip inside the cell to ...
Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or "editors," that control how those genes are read.
New research shows that cancer cells don’t just grow; they adapt when stressed. When squeezed inside tissues, they transform into more invasive, drug-resistant versions of themselves. A protein called ...
Varun Venkataramani is the winner of the 2025 Eppendorf Award for Young European Investigators. A neurologist and group leader at Heidelberg University Hospital, Germany, his work in cancer ...
The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors.
New research shows lymph nodes aren’t just cancer bystanders, they’re the command centers fueling immune attacks. Surgically removing them along with tumors may weaken treatment, while preserving them ...
Lung tumors don't just evade the immune system. They reshape it at its source. Researchers from the Icahn School of Medicine at Mount Sinai and collaborators report in the September 10 online issue of ...
A new study reveals that small cell lung cancer (SCLC) likely begins in basal stem-like cells rather than in neuroendocrine cells, marking a major shift in the understanding of this aggressive disease ...
Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...
Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...
“Our goal is really to get out all the cancer,” says Dr. Arvind Bakhru. In the operating room, the gynecologic oncologist relies on sight and feel to help identify the cancerous lesions he’ll remove.